Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 30, Number 3—March 2024
Research Letter

Staphylococcus succinus Infective Endocarditis, France

Louise Ruffier d’Epenoux, Erwan Fayoux, Frédéric Laurent, Pascale Bémer, Raphaël Lecomte, Thierry Le Tourneau, Aurélie Guillouzouic, and Stéphane CorvecComments to Author 
Author affiliations: Centre Hospitalier Universitaire, Nantes, France (L. Ruffier d’Epenoux, E. Fayoux, P. Bémer, R. Lecomte, T. Le Tourneau, A. Guillouzouic, S. Corvec); Université de Nantes, INSERM INCIT UMR 1302, Nantes (L. Ruffier d’Epenoux, S. Corvec); Université de Nantes, CNRS, INSERM UMR 1087, l’Institut du Thorax, Nantes (T. Le Tourneau); Université Claude-Bernard Lyon 1, Lyon, France (F. Laurent); Groupement Hospitalier Nord, Lyon (F. Laurent); Hôpital Croix Rousse, Lyon (F. Laurent)

Main Article

Figure

Disk diffusion testing for antimicrobial susceptibility testing of Staphylococcus succinus from a patient in France with infective endocarditis. Agar diffusion method using impregnated disks was interpreted according to the criteria of the European Committee on Antimicrobial Susceptibility Testing 2022 (version 13.0) breakpoints for oxacillin susceptibility testing (https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_13.0_Breakpoint_Tables.pdf). CEF, cephalotin; CRO: cefotaxime (PBP2); FOX, cefoxitin (PBP4); IMP, imipenem (PBP1); OXC, oxacillin (PBP3); PBP, penicillin-binding protein.

Figure. Disk diffusion testing for antimicrobial susceptibility testing of Staphylococcus succinus from a patient in France with infective endocarditis. Agar diffusion method using impregnated disks was interpreted according to the criteria of the European Committee on Antimicrobial Susceptibility Testing 2022 (version 13.0) breakpoints for oxacillin susceptibility testing (https://www.eucast.org/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_13.0_Breakpoint_Tables.pdf). CEF, cephalotin; CRO: cefotaxime (PBP2); FOX, cefoxitin (PBP4); IMP, imipenem (PBP1); OXC, oxacillin (PBP3); PBP, penicillin-binding protein.

Main Article

Page created: January 31, 2024
Page updated: February 22, 2024
Page reviewed: February 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
file_external